Physician profile
Chad E Green
NPI 1700886942
$25,549.02
in general payments reported to CMS, 2019-2025
19 companies · $879 in 2025
The $879 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,486 · 2020: $716 · 2021: $411 · 2022: $749 · 2023: $2,454 · 2024: $16K · 2025: $879.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,500 · Food and Beverage: $2,687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,500.00 |
| Food and Beverage | $2,686.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $20,896.38 | 2019-2025 | Cvi Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $2,563.60 | 2019-2025 | Tryptyr, Precision 7 |
| Tarsus Pharmaceuticals, INC. | $388.26 | 2024-2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $282.92 | 2019-2025 | Acuvue |
| Optovue, INC. | $262.44 | 2019-2020 | |
| Lkc Technologies, INC. | $231.50 | 2023-2024 | |
| Bausch & Lomb Americas INC. | $223.52 | 2023-2025 | Miebo, Vyzulta, Infuse |
| Sun Pharmaceutical Industries INC. | $172.42 | 2022-2025 | Cequa |
| Glaukos Corporation | $138.35 | 2024 | Ce-Marked Kxla System |
| Oyster Point Pharma, INC. | $118.70 | 2022-2025 | Tyrvaya, Ryzumvi |
| Maculogix, INC. | $65.44 | 2019-2020 | |
| Abbvie INC. | $45.48 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $38.75 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $35.65 | 2022 | |
| Abb Con-Cise Optical Group LLC | $21.15 | 2025 | Spectacle Lenses, Contact Lens |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $20.11 | 2022 | |
| Thea Pharma INC. | $18.41 | 2025 | Iyuzeh |
| Kala Pharmaceuticals, INC. | $14.63 | 2021 | |
| Aerie Pharmaceuticals, INC. | $11.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.